Tag: CLDN18

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CLDN18

Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin ...

Added to Collection on: 2020-11-24 18:22:30

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Immune system
Biotechnology
Monoclonal antibody
Humanized antibody
Antibody
CLDN18
Antibody Solutions
Epitope mapping
integral molecular, inc.

Click the tags to see associated articles and topics

View Article Details
I-Mab and ABL Bio Receive US FDA Approval to Initiate Phase 1 Trial of Bispecific Antibody TJ ...

Added to Collection on: 2021-03-30 12:00:00

Tags for this article:

Medical specialties
Clinical medicine
Medicine
Immunology
Monoclonal antibody therapy
Monoclonal antibody
Cancer immunotherapy
CD137
CLDN18
Bispecific monoclonal antibody
TJ
I-Mab

Click the tags to see associated articles and topics

View Article Details
Astellas Provides Update on Zolbetuximab Biologics License Application in U.S. | Antibodies

Added to Collection on: 2024-01-09 15:19:16

Tags for this article:

Food and Drug Administration
Astellas Pharma
Mitsubishi UFJ Financial Group
Monoclonal antibodies
Zolbetuximab
CLDN18
Prescription Drug User Fee Act
Biologics license application
u.s. food and drug administration
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Claudin 18.2 Targeted Therapy Market Forecast & Clinical Trials Insights 2024-2029

Added to Collection on: 2025-05-22 11:49:30

Tags for this article:

Antineoplastic drugs
Cancer
Orphan drugs
Zolbetuximab
CLDN18
Targeted therapy
Astellas Pharma
Cancer immunotherapy
Cancer treatment
Oncology
HER2
Pembrolizumab
Clinical Trials By Company
ResearchAndMarkets.com

Click the tags to see associated articles and topics

View Article Details
Claudin 18.2-Directed Oncology Therapeutics--A Fast-Growing Market with Blockbuster Potential

Added to Collection on: 2025-07-23 21:34:33

Tags for this article:

Antineoplastic drugs
Biotechnology
Monoclonal antibodies
Orphan drugs
Zolbetuximab
CLDN18
Pharmaceutical companies
Astellas Pharma
AstraZeneca
Checkpoint inhibitor
Biopharmaceutical
Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details
Book a Demo